Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

100%

3 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4
3(100.0%)
3Total
Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02727322Phase 4Completed

Nitrofurantoin Prophylaxis During Catheter-managed Acute Urinary Retention After Pelvic Reconstructive Surgery

Role: lead

NCT02155738Phase 4Completed

IV Acetaminophen for Postoperative Pain After Pelvic Organ Prolapse Repair

Role: lead

NCT01805310Phase 4Completed

Pre-operative Bowel Preparation Prior to Minimally Invasive Sacral Colpopexy

Role: lead

All 3 trials loaded